Tessera Therapeutics names former Merck executive as new CEO
Go back to Tessera Therapeutics names former Merck executive as new CEO| Merck & Co. (NYSE: MRK) | Delayed: 150.91 +1.41 (0.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.50 | 52 Week High | $65.46 | |||
| Open | $148.69 | 52 Week Low | $47.97 | |||
| Day High | $153.57 | P/E | 102.66 | |||
| Day Low | $148.04 | EPS | $1.47 | |||
| Volume | 11,172,873 | |||||
| Regeneron (NASDAQ: REGN) | Delayed: 803.90 +5.73 (0.72%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $798.17 | 52 Week High | $592.36 | |||
| Open | $802.48 | 52 Week Low | $325.35 | |||
| Day High | $811.66 | P/E | 211.00 | |||
| Day Low | $791.31 | EPS | $3.81 | |||
| Volume | 600,256 | |||||
